Literature DB >> 25048530

Inverse spatial distribution of brain metastases and white matter hyperintensities in advanced lung and non-lung cancer patients.

Carlo Cosimo Quattrocchi1, Yuri Errante, Carlo Augusto Mallio, Luciano Carideo, Laura Scarciolla, Daniele Santini, Giuseppe Tonini, Bruno Beomonte Zobel.   

Abstract

The aim of this study was to test by means of a voxel-based approach the hypothesis that there is a different spatial distribution of brain metastases (BM) and white matter hyperintensities (WMH) and that the presence of WMH affects the location of BM in lung and non-lung cancer patients. Two-hundred consecutive cancer patients at first diagnosis of BM were included. Images were acquired using a 1.5 Tesla MRI system (Magnetom Avanto B13, Siemens, Erlangen, Germany). Axial FLAIR T2 weighted images and gadolinium-enhanced T1 weighted images were post-processed for segmentation, co-registration and analysis. Binary lesion masks were created for WMH and BM, using Volumes of Interest. Lesion probability maps were generated and the voxel-based lesion-symptom mapping approach was used to model each voxel and to calculate a non parametric statistics (Brunner-Munzel test) describing the differences between the groups. In the lung cancer group we found higher frequency of BM in WMH- than in WMH+ patients in the occipital lobe and the cerebellum. In contrast, BM were more frequent in the right frontal lobe in WMH+ than in WMH- patients. We suggest that there exists an inverse brain spatial distribution between WMH and BM. In lung cancer patients, the presence of WMH seems to shift the distribution of BM toward locations different than what it is expected based on primary tumor.

Entities:  

Mesh:

Year:  2014        PMID: 25048530     DOI: 10.1007/s11060-014-1554-7

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  37 in total

1.  Spatial brain distribution of intra-axial metastatic lesions in breast and lung cancer patients.

Authors:  Carlo Cosimo Quattrocchi; Yuri Errante; Chiara Gaudino; Carlo Augusto Mallio; Alessandro Giona; Daniele Santini; Giuseppe Tonini; Bruno Beomonte Zobel
Journal:  J Neurooncol       Date:  2012-07-18       Impact factor: 4.130

2.  Attributes of brain metastases from breast and lung cancer.

Authors:  Kyle Hengel; Gurinder Sidhu; Jai Choi; Jeremy Weedon; Emmanuel Nwokedi; Constantine A Axiotis; Xianyuan Song; Albert S Braverman
Journal:  Int J Clin Oncol       Date:  2012-03-02       Impact factor: 3.402

3.  Predilection of brain metastasis in gray and white matter junction and vascular border zones.

Authors:  T L Hwang; T P Close; J M Grego; W L Brannon; F Gonzales
Journal:  Cancer       Date:  1996-04-15       Impact factor: 6.860

4.  Central nervous system metastasis from breast carcinoma. Autopsy study.

Authors:  Y Tsukada; A Fouad; J W Pickren; W W Lane
Journal:  Cancer       Date:  1983-12-15       Impact factor: 6.860

5.  Clinical correlates of white matter findings on cranial magnetic resonance imaging of 3301 elderly people. The Cardiovascular Health Study.

Authors:  W T Longstreth; T A Manolio; A Arnold; G L Burke; N Bryan; C A Jungreis; P L Enright; D O'Leary; L Fried
Journal:  Stroke       Date:  1996-08       Impact factor: 7.914

Review 6.  Heterogeneity of small vessel disease: a systematic review of MRI and histopathology correlations.

Authors:  Alida A Gouw; Alexandra Seewann; Wiesje M van der Flier; Frederik Barkhof; Annemieke M Rozemuller; Philip Scheltens; Jeroen J G Geurts
Journal:  J Neurol Neurosurg Psychiatry       Date:  2010-10-09       Impact factor: 10.154

7.  Nomogram to predict subsequent brain metastasis in patients with metastatic breast cancer.

Authors:  Olivier Graesslin; Bassam S Abdulkarim; Charles Coutant; Florence Huguet; Zsolt Gabos; Limin Hsu; Olivier Marpeau; Serge Uzan; Lajos Pusztai; Eric A Strom; Gabriel N Hortobagyi; Roman Rouzier; Nuhad K Ibrahim
Journal:  J Clin Oncol       Date:  2010-03-22       Impact factor: 44.544

8.  Brain magnetic resonance imaging abnormalities in patients with heart failure.

Authors:  Raymond L C Vogels; Wiesje M van der Flier; Barbera van Harten; Alida A Gouw; Philip Scheltens; Jutta M Schroeder-Tanka; Henry C Weinstein
Journal:  Eur J Heart Fail       Date:  2007-08-23       Impact factor: 15.534

9.  Brain white matter hyperintensities are associated with carotid intraplaque hemorrhage.

Authors:  Nishath Altaf; Paul S Morgan; Alan Moody; Shane T MacSweeney; J R Gladman; Dorothee P Auer
Journal:  Radiology       Date:  2008-07       Impact factor: 11.105

10.  Small vessel ischemic disease of the brain and brain metastases in lung cancer patients.

Authors:  Peter J Mazzone; Nicola Marchi; Vince Fazio; J Michael Taylor; Thomas Masaryk; Luke Bury; Tarek Mekhail; Damir Janigro
Journal:  PLoS One       Date:  2009-09-30       Impact factor: 3.240

View more
  4 in total

1.  Predicting brain metastases for non-small cell lung cancer based on magnetic resonance imaging.

Authors:  Gang Yin; Churong Li; Heng Chen; Yangkun Luo; Lucia Clara Orlandini; Pei Wang; Jinyi Lang
Journal:  Clin Exp Metastasis       Date:  2017-01-18       Impact factor: 5.150

2.  White matter lesions reduce number of brain metastases in different cancers: a high-resolution MRI study.

Authors:  Benjamin-Andreas Berk; Sandra Nagel; K Hering; S Paschke; Karl-Titus Hoffmann; Rolf-Dieter Kortmann; Chiara Gaudino; Clemens Seidel
Journal:  J Neurooncol       Date:  2016-08-17       Impact factor: 4.130

3.  Distribution of brain metastases: low-risk metastasis areas may be avoided when treating with whole-brain radiotherapy.

Authors:  Binwei Lin; Dan Huang; Xiyue Yang; Yu Zhang; Feng Gang; Xiao Bo Du
Journal:  Cancer Imaging       Date:  2020-04-22       Impact factor: 3.909

4.  Inverse Perfusion Requirements of Supra- and Infratentorial Brain Metastases Formation.

Authors:  Tanja Schneider; André Kemmling; Julian Schroeder; Klaus Pantel; Markus Glatzel; Gerhard Schoen; Malte Mohme; Jens Fiehler; Susanne Gellißen
Journal:  Front Neurol       Date:  2018-05-30       Impact factor: 4.003

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.